Are antihypertensive drugs used to maximally reduce cardiovascular risk in dialysis patients?

被引：2

作者：

Garg, J ^{[1
]}

Bakris, GL

机构：

[1] Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA

[2] Rush Univ, Med Ctr, Hypertens Clin Res Ctr, Chicago, IL 60612 USA

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2003年 / 42卷 / 06期

关键词：

D O I：

10.1053/j.ajkd.2003.09.025

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1301 / 1304

页数：4

共 26 条

[1] Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction [J].

Berger, AK ;

Duval, S ;

Krumholz, HM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) :201-208

[2] Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial [J].

Black, HR ;

Elliott, WJ ;

Grandits, G ;

Grambsch, P ;

Lucente, T ;

White, WB ;

Neaton, JD ;

Grimm, RH ;

Hansson, L ;

Lacourcière, Y ;

Muller, J ;

Sleight, P ;

Weber, MA ;

Williams, G ;

Wittes, J ;

Zanchetti, A ;

Anders, RJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16) :2073-2082

[3] Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects [J].

Cannella, G ;

Paoletti, E ;

Delfino, R ;

Peloso, G ;

Rolla, D ;

Molinari, S .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (05) :659-664

[4] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].

Chobanian, AV ;

Bakris, GL ;

Black, HR ;

Cushman, WC ;

Green, LA ;

Izzo, JL ;

Jones, DW ;

Materson, BJ ;

Oparil, S ;

Wright, JT ;

Roccella, EJ .

HYPERTENSION, 2003, 42 (06) :1206-1252

[5] Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy -: A prospective, placebo-controlled trial [J].

Cice, G ;

Ferrara, L ;

D'Andrea, A ;

D'Isa, S ;

Di Benedetto, A ;

Cittadini, A ;

Russo, PE ;

Golino, P ;

Calabrò, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) :1438-1444

[6] Cardiovascular mortality in end-stage renal disease [J].

Collins, AJ .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04) :163-167

[7] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

[8] ACE inhibitors and survival of hemodialysis patients [J].

Efrati, S ;

Zaidenstein, R ;

Dishy, V ;

Beberashvili, I ;

Sharist, M ;

Averbukh, Z ;

Golik, A ;

Weissgarten, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (05) :1023-1029

[9] Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study [J].

Foley, RN ;

Herzog, CA ;

Collins, AJ .

KIDNEY INTERNATIONAL, 2002, 62 (05) :1784-1790

[10] Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients [J].

Griffith, TF ;

Chua, BSY ;

Allen, AS ;

Klassen, PS ;

Reddan, DN ;

Szczech, LA .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (06) :1260-1269

← 1 2 3 →